Myosfascial Trigger-Points and Effects on Neuromuscular Response

Treatment of Myosfascial Trigger-Points of Gastrocnemius and Its Effects on the Neuromuscular Response

The aim of this study is to analyze the effects of the treatment of the Myosfascial Trigger-Points detected in the gastrocnemius muscles on the neuromuscular response.

Study Overview

• Status: Unknown
• Conditions: Myofascial Trigger Point Pain
• Intervention / Treatment: Other: Pressure Release

• Study Type: Interventional
• Enrollment (Actual): 29
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Spain
  • Barcelona
    • Sant Cugat Del Vallès, Barcelona, Spain, 08195
      • Universitat Internacional de Catalunya

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 40 years (Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Subjets with both active or latent Myosfascial Trigger Points

Exclusion Criteria:

• Pregnant women
• Musculoskeletal problems in the last month
• Surgical interventions in he knee, hip, ankle, back or neck in tha last 6 months
• Psychological or nervous alterations
• Uncomprehension of the study protocol

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: Control arm; No intervention
Experimental: Pressure Release; Digitopressure treatment of the Myosfascial Trigger Points	Other: Pressure Release; Subjets receive digitopressure during 90 seconds for the treatment of the Myosfascial Trigger Points

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
change of neuromuscular stiffness of the gastrocnemious muscles	biomechanical property of a muscle that characterizes the resistance to an external force that deforms its initial shape, using a "Myoton".	10 minutes before the intervention, and 1 minute after the intervention
change of elasticity of the gastrocnemious muscles	Biomechanical property of a muscle that characterizes the ability to recover its initial shape after the removal of the external force that lead to its deformation, using a "Myoton".	10 minutes before the intervention, and 1 minute after the intervention
change of relaxation of the gastrocnemious muscles	Time for a muscle to recover its shape from deformation after the removal of an external force, using a "Myoton".	10 minutes before the intervention, and 1 minute after the intervention

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
change of active dorsiflexion ROM	Active range of movement of the dorsiflexion of the ankle, using an inclinometer (degrees).	4 minutes before the intervention, and 6 minute after the intervention
change of pasive dorsiflexion ROM	Pasive range of movement of the dorsiflexion of the ankle, using an inclinometer (degrees).	2 minutes before the intervention, and 8 minute after the intervention
change of gastrocnemious strength	Isometric strength of the gastrocnemious muscles using a handheld dynamometer "microFET 2" (newtons).	5 minutes before the intervention, and 5 minute after the intervention
change of pain intensity	How much pressure needs to be applied to cause pain	8 minutes before the intervention, and 2 minute after the intervention
change of pressure-pain threshold	How much pain the pacient reports while a pressure of 1kg/cm²/s is being applied over his gastrocnemious muscle	7 minutes before the intervention, and 3 minute after the intervention

Collaborators and Investigators

• Sponsor: Universitat Internacional de Catalunya
• Investigators: Principal Investigator: Albert Pérez-Bellmunt, PhD, Anatomy lecturer

Study record dates

Study Major Dates

• Study Start (Actual): May 2, 2019
• Primary Completion (Anticipated): June 7, 2019
• Study Completion (Anticipated): June 7, 2019

Study Registration Dates

• First Submitted: May 3, 2019
• First Submitted That Met QC Criteria: May 6, 2019
• First Posted (Actual): May 7, 2019

Study Record Updates

• Last Update Posted (Actual): May 7, 2019
• Last Update Submitted That Met QC Criteria: May 6, 2019
• Last Verified: May 1, 2019

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Musculoskeletal Diseases; Muscular Diseases; Myofascial Pain Syndromes
• Other Study ID Numbers: Protocol ID : P3/03

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No